Literature DB >> 15601827

Neutrophil elastase is important for PML-retinoic acid receptor alpha activities in early myeloid cells.

Andrew A Lane1, Timothy J Ley.   

Abstract

Expression of the PML-retinoic acid receptor alpha (PML-RARalpha) fusion protein is the initiating genetic event for acute promyelocytic leukemia (APL), but the molecular mechanisms responsible for disease initiation are not yet clear. Several observations have suggested that early myeloid cells are uniquely susceptible to transformation by PML-RARalpha. Recently, we have shown that the early myeloid-specific protease neutrophil elastase is important for APL development in the mouse. To better understand the role of neutrophil elastase for the pathogenesis of APL, we examined the consequences of PML-RARalpha expression in early myeloid cells with or without neutrophil elastase. We found that high-level PML-RARalpha expression was associated with cellular toxicity that was dependent on the expression of neutrophil elastase; a mutant form of PML-RARalpha that resisted neutrophil elastase cleavage was not toxic. When PML-RARalpha was expressed at very low levels in the early myeloid cells of mice, it induced myeloid expansion and delayed myeloid maturation; neutrophil elastase was also required for these activities. The activities of PML-RARalpha in early myeloid cells are therefore strongly influenced by the presence of neutrophil elastase. To assure physiologic relevance, PML-RARalpha functions should be evaluated in neutrophil elastase-expressing early myeloid cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15601827      PMCID: PMC538790          DOI: 10.1128/MCB.25.1.23-33.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Dynamic shuttling and intranuclear mobility of nuclear hormone receptors.

Authors:  Padma Maruvada; Christopher T Baumann; Gordon L Hager; Paul M Yen
Journal:  J Biol Chem       Date:  2002-12-26       Impact factor: 5.157

2.  Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein.

Authors:  P F Ferrucci; F Grignani; M Pearson; M Fagioli; I Nicoletti; P G Pelicci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

3.  Multilineage gene expression precedes commitment in the hemopoietic system.

Authors:  M Hu; D Krause; M Greaves; S Sharkis; M Dexter; C Heyworth; T Enver
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

4.  Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.

Authors:  L Z He; C Tribioli; R Rivi; D Peruzzi; P G Pelicci; V Soares; G Cattoretti; P P Pandolfi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells.

Authors:  F Grignani; P F Ferrucci; U Testa; G Talamo; M Fagioli; M Alcalay; A Mencarelli; F Grignani; C Peschle; I Nicoletti
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

6.  Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells.

Authors:  H Ogawa; S Inouye; F I Tsuji; K Yasuda; K Umesono
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

7.  Transgenic expression of PML/RARalpha impairs myelopoiesis.

Authors:  E Early; M A Moore; A Kakizuka; K Nason-Burchenal; P Martin; R M Evans; E Dmitrovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

8.  Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences.

Authors:  J L Grisolano; R L Wesselschmidt; P G Pelicci; T J Ley
Journal:  Blood       Date:  1997-01-15       Impact factor: 22.113

9.  A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.

Authors:  D Brown; S Kogan; E Lagasse; I Weissman; M Alcalay; P G Pelicci; S Atwater; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

10.  Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia.

Authors:  A G Turhan; F M Lemoine; C Debert; M L Bonnet; C Baillou; F Picard; E A Macintyre; B Varet
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

View more
  23 in total

1.  IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ.

Authors:  Li-Chung Hsu; Thomas Enzler; Jun Seita; Anjuli M Timmer; Chih-Yuan Lee; Ting-Yu Lai; Guann-Yi Yu; Liang-Chuan Lai; Vladislav Temkin; Ursula Sinzig; Thiha Aung; Victor Nizet; Irving L Weissman; Michael Karin
Journal:  Nat Immunol       Date:  2010-12-19       Impact factor: 25.606

2.  A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemia.

Authors:  Geoffrey L Uy; Andrew A Lane; John S Welch; Nicole R Grieselhuber; Jacqueline E Payton; Timothy J Ley
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

3.  Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.

Authors:  Matthew J Walter; John S Park; Rhonda E Ries; Steven K M Lau; Michael McLellan; Sara Jaeger; Richard K Wilson; Elaine R Mardis; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-19       Impact factor: 11.205

Review 4.  Neutrophil elastase in cyclic and severe congenital neutropenia.

Authors:  Marshall S Horwitz; Zhijun Duan; Brice Korkmaz; Hu-Hui Lee; Matthew E Mealiffe; Stephen J Salipante
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

5.  PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice.

Authors:  John S Welch; Wenlin Yuan; Timothy J Ley
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

6.  Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice.

Authors:  John S Welch; Jeffery M Klco; Nobish Varghese; Rakesh Nagarajan; Timothy J Ley
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

7.  Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.

Authors:  Matthew J Walter; John S Park; Steven K M Lau; Xia Li; Andrew A Lane; Rakesh Nagarajan; William D Shannon; Timothy J Ley
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

8.  The PML domain of PML-RARα blocks senescence to promote leukemia.

Authors:  Katharina Korf; Harald Wodrich; Alexander Haschke; Corinne Ocampo; Lena Harder; Friederike Gieseke; Annika Pollmann; Kevin Dierck; Sebastian Prall; Hannah Staege; Hui Ma; Martin A Horstmann; Ronald M Evans; Thomas Sternsdorf
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

Review 9.  ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.

Authors:  Marshall S Horwitz; Seth J Corey; H Leighton Grimes; Timothy Tidwell
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-07       Impact factor: 3.722

10.  PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors.

Authors:  S Wojiski; F C Guibal; T Kindler; B H Lee; J L Jesneck; A Fabian; D G Tenen; D G Gilliland
Journal:  Leukemia       Date:  2009-03-26       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.